Porton Pharma Solutions (SZSE:300363) Cash And Cash Equivalents : ¥1,483 Mil (As of Jun. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Porton Pharma Solutions Cash And Cash Equivalents?

Porton Pharma Solutions's quarterly cash and cash equivalents declined from Dec. 2023 (¥1,966.56 Mil) to Mar. 2024 (¥1,806.65 Mil) but then stayed the same from Mar. 2024 (¥1,806.65 Mil) to Jun. 2024 (¥1,483.01 Mil).

Porton Pharma Solutions's annual cash and cash equivalents increased from Dec. 2021 (¥1,216.87 Mil) to Dec. 2022 (¥2,850.42 Mil) but then declined from Dec. 2022 (¥2,850.42 Mil) to Dec. 2023 (¥1,966.56 Mil).

Porton Pharma Solutions Cash And Cash Equivalents Historical Data

The historical data trend for Porton Pharma Solutions's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Porton Pharma Solutions Cash And Cash Equivalents Chart

Porton Pharma Solutions Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash And Cash Equivalents

Get a 7-Day Free Trial

1,174.68

1,262.06

1,216.87

2,850.42

1,966.56

Porton Pharma Solutions Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Cash And Cash Equivalents	Get a 7-Day Free Trial															2,481.27	2,121.07	1,966.56	1,806.65	1,483.01

Porton Pharma Solutions Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Porton Pharma Solutions (SZSE:300363) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Porton Pharma Solutions Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Porton Pharma Solutions's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Porton Pharma Solutions Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Porton Pharma Solutions Ltd (SZSE:300363) » Definitions » Cash And Cash Equivalents

Traded in Other Exchanges

N/A

Address

Fangzheng Avenue, Porton New Drug Outsourcing Service and R&D Center, Shuitu, Beibei District, Chongqing, CHN, 400714

Website

http://www.porton.cn

Porton Pharma Solutions Ltd is a China-based external manufacturing supplier of custom drug intermediates and Active Pharmaceutical Ingredients (APIs) to pharmaceutical companies. It is engaged in the process development activities and pilot-scale and commercial-scale manufacturing activities.

Executives

Wang Zhong Neng	Executives
Yu Yong Mei	Executives
Sun Min	Executives
Ji Yao Hui	Executives
Ju Nian Feng	Directors, executives
Tan Jun	Supervisors
Xu Ai Wu	Directors, executives
Guo Yong Qing	Independent director
	Director
	Director
Ceng Hui	Supervisors
Chen Bei	Executives

Porton Pharma Solutions Headlines

No Headlines